3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
14
Carcinoma, Non-Small-Cell Lung
5
Prostatic Neoplasms
4
Lung Neoplasms
3
Stomach Neoplasms
2
Esophageal Neoplasms
2
Breast Neoplasms, Male
2
Uterine Neoplasms
1
Thrombosis
1
Peritoneal Neoplasms
1
Pathological and Imaging Examinations Confirmed Metastatic Prostate Cancer
1
Pancreatic Neoplasms
1
Non-squamous Non-small Cell Lung Cancer
1
Non-Muscle Invasive Bladder Neoplasms
1
Nasopharyngeal Neoplasms
1
Nasopharyngeal Carcinoma
1
NSCLC
1
Inflammatory Breast Neoplasms
1
Infections
1
Hypopharyngeal Neoplasms
1
Hormone Refractory Prostate Cancer
1
Head and Neck Neoplasms
1
Esophageal Squamous Cell Carcinoma
1
Drug-Related Side Effects and Adverse Reactions
1
Carcinogenesis
1
Breast Neoplasm Female
1
Breast Diseases
1
Amenorrhea
1
Adenocarcinoma
1
Interventions
salicylhydroxamic acid
1
fluorescein isothiocyanate-keyhole limpet hemocyanin
1
edoxaban
1
apixaban
1
X-Rays
1
Warfarin
1
Technetium Tc 99m Sulfur Colloid
1
Saline Solution
1
Rivaroxaban
1
Radiotherapy, Conformal
1
Physical Therapy Modalities
1
Photons
1
Paclitaxel
1
Musculoskeletal Manipulations
1
Fondaparinux
1
Enoxaparin
1
Docetaxel
1
Dexmedetomidine
1
Dalteparin
1
Dabigatran
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Thrombosis
×
Docetaxel
×
Clear all
NCT04324346
2021-03-18
PICC&PAC
Swedish Red Cross University College
Phase NA
Completed
250 enrolled